Your browser doesn't support javascript.
loading
Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients.
Kurashige, Takashi; Morino, Hiroyuki; Ueno, Hiroki; Murao, Tomomi; Watanabe, Tomoaki; Hinoi, Takao; Nishino, Ichizo; Torii, Tsuyoshi; Maruyama, Hirofumi.
Affiliation
  • Kurashige T; Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan. takashi-kurashige@hiroshima-u.ac.jp.
  • Morino H; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan. takashi-kurashige@hiroshima-u.ac.jp.
  • Ueno H; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Murao T; Department of Medical Genetics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Watanabe T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Hinoi T; Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
  • Nishino I; Department of Neurology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
  • Torii T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Maruyama H; Division of Clinical and Molecular Genetics, Hiroshima University Hospital, Hiroshima, Japan.
J Hum Genet ; 68(2): 91-95, 2023 Feb.
Article in En | MEDLINE | ID: mdl-36336708
Facioscapulohumeral dystrophy type1 (FSHD1) patients with a shortened D4Z4 repeat containing the DUX4 gene have a broad spectrum of clinical manifestations. In addition, high expression of DUX4 protein with an aberrant C terminus is frequently identified in B cell acute lymphoblastic leukemia. We investigated clinical manifestations in 31 FSHD1 patients and 30 non-affected individuals. Gastrointestinal cancers (gastric and colorectal cancers) increased after the age of 40 years and were more frequently observed in FSHD1 patients (n = 10) than in non-affected individuals (n = 2, p = 0.0217), though the incidence of cancers occurring in non-gastrointestinal tissues of FSHD1 patients was the same as that of non-affected individuals (p > 0.999). These comorbidities of FSHD1 patients were not associated with D4Z4 repeat number. Our results suggest that gastrointestinal cancers are among the extramuscular manifestations of adult FSHD1 patients, and do not depend on D4Z4 repeat number.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Muscular Dystrophy, Facioscapulohumeral / Gastrointestinal Neoplasms Limits: Adult / Humans Language: En Journal: J Hum Genet Journal subject: GENETICA MEDICA Year: 2023 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Muscular Dystrophy, Facioscapulohumeral / Gastrointestinal Neoplasms Limits: Adult / Humans Language: En Journal: J Hum Genet Journal subject: GENETICA MEDICA Year: 2023 Type: Article Affiliation country: Japan